Industry Research Reports
Home > Reports > Chemical & Material > Semi-Solid Dose- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Semi-Solid Dose- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Chemical & Material
Published Date: 2025-02-14
Pages: 99 Pages
Report ld: 3795005
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Semi-Solid Dose was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
North American market for Semi-Solid Dose was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Semi-Solid Dose was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Semi-Solid Dose was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Semi-Solid Dose include Johnson & Johnson, Merck & Co, Bayer AG, Hisamitsu Pharmaceutical, Glenmark Pharmaceuticals, Cipla Ltd, Nestle SA, Novartis AG, GlaxoSmithKline plc, Bausch Health Companies, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Semi-Solid Dose, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Semi-Solid Dose by region & country, by Type, and by Application.
The Semi-Solid Dose market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Semi-Solid Dose.
MARKET SEGMENTATION
By Company
- Johnson & Johnson
- Merck & Co
- Bayer AG
- Hisamitsu Pharmaceutical
- Glenmark Pharmaceuticals
- Cipla Ltd
- Nestle SA
- Novartis AG
- GlaxoSmithKline plc
- Bausch Health Companies
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Ointments
- Pastes
- Gels
Segment by Application
- Skin
- Nasal Cavity
- Vaginal Cavity
- Rectal Cavity
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Semi-Solid Dose manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Semi-Solid Dose in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Semi-Solid Dose in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Semi-Solid Dose Product Introduction
1.2 Global Semi-Solid Dose Market Size Forecast
1.2.1 Global Semi-Solid Dose Sales Value (2020-2031)
1.2.2 Global Semi-Solid Dose Sales Volume (2020-2031)
1.2.3 Global Semi-Solid Dose Sales Price (2020-2031)
1.3 Semi-Solid Dose Market Trends & Drivers
1.3.1 Semi-Solid Dose Industry Trends
1.3.2 Semi-Solid Dose Market Drivers & Opportunity
1.3.3 Semi-Solid Dose Market Challenges
1.3.4 Semi-Solid Dose Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Semi-Solid Dose Players Revenue Ranking (2024)
2.2 Global Semi-Solid Dose Revenue by Company (2020-2025)
2.3 Global Semi-Solid Dose Players Sales Volume Ranking (2024)
2.4 Global Semi-Solid Dose Sales Volume by Company Players (2020-2025)
2.5 Global Semi-Solid Dose Average Price by Company (2020-2025)
2.6 Key Manufacturers Semi-Solid Dose Manufacturing Base and Headquarters
2.7 Key Manufacturers Semi-Solid Dose Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Semi-Solid Dose
2.9 Semi-Solid Dose Market Competitive Analysis
2.9.1 Semi-Solid Dose Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Semi-Solid Dose Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Semi-Solid Dose as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Ointments
3.1.2 Pastes
3.1.3 Gels
3.2 Global Semi-Solid Dose Sales Value by Type
3.2.1 Global Semi-Solid Dose Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Semi-Solid Dose Sales Value, by Type (2020-2031)
3.2.3 Global Semi-Solid Dose Sales Value, by Type (%) (2020-2031)
3.3 Global Semi-Solid Dose Sales Volume by Type
3.3.1 Global Semi-Solid Dose Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Semi-Solid Dose Sales Volume, by Type (2020-2031)
3.3.3 Global Semi-Solid Dose Sales Volume, by Type (%) (2020-2031)
3.4 Global Semi-Solid Dose Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Skin
4.1.2 Nasal Cavity
4.1.3 Vaginal Cavity
4.1.4 Rectal Cavity
4.1.5 Others
4.2 Global Semi-Solid Dose Sales Value by Application
4.2.1 Global Semi-Solid Dose Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Semi-Solid Dose Sales Value, by Application (2020-2031)
4.2.3 Global Semi-Solid Dose Sales Value, by Application (%) (2020-2031)
4.3 Global Semi-Solid Dose Sales Volume by Application
4.3.1 Global Semi-Solid Dose Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Semi-Solid Dose Sales Volume, by Application (2020-2031)
4.3.3 Global Semi-Solid Dose Sales Volume, by Application (%) (2020-2031)
4.4 Global Semi-Solid Dose Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Semi-Solid Dose Sales Value by Region
5.1.1 Global Semi-Solid Dose Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Semi-Solid Dose Sales Value by Region (2020-2025)
5.1.3 Global Semi-Solid Dose Sales Value by Region (2026-2031)
5.1.4 Global Semi-Solid Dose Sales Value by Region (%), (2020-2031)
5.2 Global Semi-Solid Dose Sales Volume by Region
5.2.1 Global Semi-Solid Dose Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Semi-Solid Dose Sales Volume by Region (2020-2025)
5.2.3 Global Semi-Solid Dose Sales Volume by Region (2026-2031)
5.2.4 Global Semi-Solid Dose Sales Volume by Region (%), (2020-2031)
5.3 Global Semi-Solid Dose Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Semi-Solid Dose Sales Value, 2020-2031
5.4.2 North America Semi-Solid Dose Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Semi-Solid Dose Sales Value, 2020-2031
5.5.2 Europe Semi-Solid Dose Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Semi-Solid Dose Sales Value, 2020-2031
5.6.2 Asia Pacific Semi-Solid Dose Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Semi-Solid Dose Sales Value, 2020-2031
5.7.2 South America Semi-Solid Dose Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Semi-Solid Dose Sales Value, 2020-2031
5.8.2 Middle East & Africa Semi-Solid Dose Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Semi-Solid Dose Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Semi-Solid Dose Sales Value
6.2.1 Key Countries/Regions Semi-Solid Dose Sales Value, 2020-2031
6.2.2 Key Countries/Regions Semi-Solid Dose Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Semi-Solid Dose Sales Value, 2020-2031
6.3.2 United States Semi-Solid Dose Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Semi-Solid Dose Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Semi-Solid Dose Sales Value, 2020-2031
6.4.2 Europe Semi-Solid Dose Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Semi-Solid Dose Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Semi-Solid Dose Sales Value, 2020-2031
6.5.2 China Semi-Solid Dose Sales Value by Type (%), 2024 VS 2031
6.5.3 China Semi-Solid Dose Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Semi-Solid Dose Sales Value, 2020-2031
6.6.2 Japan Semi-Solid Dose Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Semi-Solid Dose Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Semi-Solid Dose Sales Value, 2020-2031
6.7.2 South Korea Semi-Solid Dose Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Semi-Solid Dose Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Semi-Solid Dose Sales Value, 2020-2031
6.8.2 Southeast Asia Semi-Solid Dose Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Semi-Solid Dose Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Semi-Solid Dose Sales Value, 2020-2031
6.9.2 India Semi-Solid Dose Sales Value by Type (%), 2024 VS 2031
6.9.3 India Semi-Solid Dose Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Information
7.1.2 Johnson & Johnson Introduction and Business Overview
7.1.3 Johnson & Johnson Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Johnson & Johnson Semi-Solid Dose Product Offerings
7.1.5 Johnson & Johnson Recent Development
7.2 Merck & Co
7.2.1 Merck & Co Company Information
7.2.2 Merck & Co Introduction and Business Overview
7.2.3 Merck & Co Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Merck & Co Semi-Solid Dose Product Offerings
7.2.5 Merck & Co Recent Development
7.3 Bayer AG
7.3.1 Bayer AG Company Information
7.3.2 Bayer AG Introduction and Business Overview
7.3.3 Bayer AG Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Bayer AG Semi-Solid Dose Product Offerings
7.3.5 Bayer AG Recent Development
7.4 Hisamitsu Pharmaceutical
7.4.1 Hisamitsu Pharmaceutical Company Information
7.4.2 Hisamitsu Pharmaceutical Introduction and Business Overview
7.4.3 Hisamitsu Pharmaceutical Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Hisamitsu Pharmaceutical Semi-Solid Dose Product Offerings
7.4.5 Hisamitsu Pharmaceutical Recent Development
7.5 Glenmark Pharmaceuticals
7.5.1 Glenmark Pharmaceuticals Company Information
7.5.2 Glenmark Pharmaceuticals Introduction and Business Overview
7.5.3 Glenmark Pharmaceuticals Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Glenmark Pharmaceuticals Semi-Solid Dose Product Offerings
7.5.5 Glenmark Pharmaceuticals Recent Development
7.6 Cipla Ltd
7.6.1 Cipla Ltd Company Information
7.6.2 Cipla Ltd Introduction and Business Overview
7.6.3 Cipla Ltd Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Cipla Ltd Semi-Solid Dose Product Offerings
7.6.5 Cipla Ltd Recent Development
7.7 Nestle SA
7.7.1 Nestle SA Company Information
7.7.2 Nestle SA Introduction and Business Overview
7.7.3 Nestle SA Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Nestle SA Semi-Solid Dose Product Offerings
7.7.5 Nestle SA Recent Development
7.8 Novartis AG
7.8.1 Novartis AG Company Information
7.8.2 Novartis AG Introduction and Business Overview
7.8.3 Novartis AG Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Novartis AG Semi-Solid Dose Product Offerings
7.8.5 Novartis AG Recent Development
7.9 GlaxoSmithKline plc
7.9.1 GlaxoSmithKline plc Company Information
7.9.2 GlaxoSmithKline plc Introduction and Business Overview
7.9.3 GlaxoSmithKline plc Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 GlaxoSmithKline plc Semi-Solid Dose Product Offerings
7.9.5 GlaxoSmithKline plc Recent Development
7.10 Bausch Health Companies
7.10.1 Bausch Health Companies Company Information
7.10.2 Bausch Health Companies Introduction and Business Overview
7.10.3 Bausch Health Companies Semi-Solid Dose Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Bausch Health Companies Semi-Solid Dose Product Offerings
7.10.5 Bausch Health Companies Recent Development
8 Industry Chain Analysis
8.1 Semi-Solid Dose Industrial Chain
8.2 Semi-Solid Dose Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Semi-Solid Dose Sales Model
8.5.2 Sales Channel
8.5.3 Semi-Solid Dose Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Semi-Solid Dose Market Trends
Table 2. Semi-Solid Dose Market Drivers & Opportunity
Table 3. Semi-Solid Dose Market Challenges
Table 4. Semi-Solid Dose Market Restraints
Table 5. Global Semi-Solid Dose Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Semi-Solid Dose Revenue Market Share by Company (2020-2025)
Table 7. Global Semi-Solid Dose Sales Volume by Company (2020-2025) & (Tons)
Table 8. Global Semi-Solid Dose Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Semi-Solid Dose Price by Company (2020-2025) & (US$/Ton)
Table 10. Key Manufacturers Semi-Solid Dose Manufacturing Base and Headquarters
Table 11. Key Manufacturers Semi-Solid Dose Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Semi-Solid Dose
Table 13. Global Semi-Solid Dose Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Semi-Solid Dose as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Semi-Solid Dose Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Semi-Solid Dose Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Semi-Solid Dose Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Semi-Solid Dose Sales Market Share in Value by Type (2020-2025)
Table 20. Global Semi-Solid Dose Sales Market Share in Value by Type (2026-2031)
Table 21. Global Semi-Solid Dose Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)
Table 22. Global Semi-Solid Dose Sales Volume by Type (2020-2025) & (Tons)
Table 23. Global Semi-Solid Dose Sales Volume by Type (2026-2031) & (Tons)
Table 24. Global Semi-Solid Dose Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Semi-Solid Dose Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Semi-Solid Dose Price by Type (2020-2025) & (US$/Ton)
Table 27. Global Semi-Solid Dose Price by Type (2026-2031) & (US$/Ton)
Table 28. Global Semi-Solid Dose Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Semi-Solid Dose Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Semi-Solid Dose Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Semi-Solid Dose Sales Market Share in Value by Application (2020-2025)
Table 32. Global Semi-Solid Dose Sales Market Share in Value by Application (2026-2031)
Table 33. Global Semi-Solid Dose Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)
Table 34. Global Semi-Solid Dose Sales Volume by Application (2020-2025) & (Tons)
Table 35. Global Semi-Solid Dose Sales Volume by Application (2026-2031) & (Tons)
Table 36. Global Semi-Solid Dose Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Semi-Solid Dose Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Semi-Solid Dose Price by Application (2020-2025) & (US$/Ton)
Table 39. Global Semi-Solid Dose Price by Application (2026-2031) & (US$/Ton)
Table 40. Global Semi-Solid Dose Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Semi-Solid Dose Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Semi-Solid Dose Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Semi-Solid Dose Sales Value by Region (2020-2025) & (%)
Table 44. Global Semi-Solid Dose Sales Value by Region (2026-2031) & (%)
Table 45. Global Semi-Solid Dose Sales Volume by Region (Tons): 2020 VS 2024 VS 2031
Table 46. Global Semi-Solid Dose Sales Volume by Region (2020-2025) & (Tons)
Table 47. Global Semi-Solid Dose Sales Volume by Region (2026-2031) & (Tons)
Table 48. Global Semi-Solid Dose Sales Volume by Region (2020-2025) & (%)
Table 49. Global Semi-Solid Dose Sales Volume by Region (2026-2031) & (%)
Table 50. Global Semi-Solid Dose Average Price by Region (2020-2025) & (US$/Ton)
Table 51. Global Semi-Solid Dose Average Price by Region (2026-2031) & (US$/Ton)
Table 52. Key Countries/Regions Semi-Solid Dose Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Semi-Solid Dose Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Semi-Solid Dose Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Semi-Solid Dose Sales Volume, (2020-2025) & (Tons)
Table 56. Key Countries/Regions Semi-Solid Dose Sales Volume, (2026-2031) & (Tons)
Table 57. Johnson & Johnson Company Information
Table 58. Johnson & Johnson Introduction and Business Overview
Table 59. Johnson & Johnson Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 60. Johnson & Johnson Semi-Solid Dose Product Offerings
Table 61. Johnson & Johnson Recent Development
Table 62. Merck & Co Company Information
Table 63. Merck & Co Introduction and Business Overview
Table 64. Merck & Co Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 65. Merck & Co Semi-Solid Dose Product Offerings
Table 66. Merck & Co Recent Development
Table 67. Bayer AG Company Information
Table 68. Bayer AG Introduction and Business Overview
Table 69. Bayer AG Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 70. Bayer AG Semi-Solid Dose Product Offerings
Table 71. Bayer AG Recent Development
Table 72. Hisamitsu Pharmaceutical Company Information
Table 73. Hisamitsu Pharmaceutical Introduction and Business Overview
Table 74. Hisamitsu Pharmaceutical Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Hisamitsu Pharmaceutical Semi-Solid Dose Product Offerings
Table 76. Hisamitsu Pharmaceutical Recent Development
Table 77. Glenmark Pharmaceuticals Company Information
Table 78. Glenmark Pharmaceuticals Introduction and Business Overview
Table 79. Glenmark Pharmaceuticals Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 80. Glenmark Pharmaceuticals Semi-Solid Dose Product Offerings
Table 81. Glenmark Pharmaceuticals Recent Development
Table 82. Cipla Ltd Company Information
Table 83. Cipla Ltd Introduction and Business Overview
Table 84. Cipla Ltd Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 85. Cipla Ltd Semi-Solid Dose Product Offerings
Table 86. Cipla Ltd Recent Development
Table 87. Nestle SA Company Information
Table 88. Nestle SA Introduction and Business Overview
Table 89. Nestle SA Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 90. Nestle SA Semi-Solid Dose Product Offerings
Table 91. Nestle SA Recent Development
Table 92. Novartis AG Company Information
Table 93. Novartis AG Introduction and Business Overview
Table 94. Novartis AG Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 95. Novartis AG Semi-Solid Dose Product Offerings
Table 96. Novartis AG Recent Development
Table 97. GlaxoSmithKline plc Company Information
Table 98. GlaxoSmithKline plc Introduction and Business Overview
Table 99. GlaxoSmithKline plc Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 100. GlaxoSmithKline plc Semi-Solid Dose Product Offerings
Table 101. GlaxoSmithKline plc Recent Development
Table 102. Bausch Health Companies Company Information
Table 103. Bausch Health Companies Introduction and Business Overview
Table 104. Bausch Health Companies Semi-Solid Dose Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 105. Bausch Health Companies Semi-Solid Dose Product Offerings
Table 106. Bausch Health Companies Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Semi-Solid Dose Downstream Customers
Table 110. Semi-Solid Dose Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Semi-Solid Dose Product Picture
Figure 2. Global Semi-Solid Dose Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Semi-Solid Dose Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Semi-Solid Dose Sales Volume (2020-2031) & (Tons)
Figure 5. Global Semi-Solid Dose Sales Price (2020-2031) & (US$/Ton)
Figure 6. Semi-Solid Dose Report Years Considered
Figure 7. Global Semi-Solid Dose Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Semi-Solid Dose Players Sales Volume Ranking (2024) & (Tons)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Semi-Solid Dose Revenue in 2024
Figure 10. Semi-Solid Dose Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Ointments Picture
Figure 12. Pastes Picture
Figure 13. Gels Picture
Figure 14. Global Semi-Solid Dose Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Semi-Solid Dose Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Semi-Solid Dose Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)
Figure 17. Global Semi-Solid Dose Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Semi-Solid Dose Price by Type (2020-2031) & (US$/Ton)
Figure 19. Product Picture of Skin
Figure 20. Product Picture of Nasal Cavity
Figure 21. Product Picture of Vaginal Cavity
Figure 22. Product Picture of Rectal Cavity
Figure 23. Product Picture of Others
Figure 24. Global Semi-Solid Dose Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 25. Global Semi-Solid Dose Sales Value Market Share by Application, 2024 & 2031
Figure 26. Global Semi-Solid Dose Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)
Figure 27. Global Semi-Solid Dose Sales Volume Market Share by Application, 2024 & 2031
Figure 28. Global Semi-Solid Dose Price by Application (2020-2031) & (US$/Ton)
Figure 29. North America Semi-Solid Dose Sales Value (2020-2031) & (US$ Million)
Figure 30. North America Semi-Solid Dose Sales Value by Country (%), 2024 VS 2031
Figure 31. Europe Semi-Solid Dose Sales Value, (2020-2031) & (US$ Million)
Figure 32. Europe Semi-Solid Dose Sales Value by Country (%), 2024 VS 2031
Figure 33. Asia Pacific Semi-Solid Dose Sales Value, (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Semi-Solid Dose Sales Value by Region (%), 2024 VS 2031
Figure 35. South America Semi-Solid Dose Sales Value, (2020-2031) & (US$ Million)
Figure 36. South America Semi-Solid Dose Sales Value by Country (%), 2024 VS 2031
Figure 37. Middle East & Africa Semi-Solid Dose Sales Value, (2020-2031) & (US$ Million)
Figure 38. Middle East & Africa Semi-Solid Dose Sales Value by Country (%), 2024 VS 2031
Figure 39. Key Countries/Regions Semi-Solid Dose Sales Value (%), (2020-2031)
Figure 40. Key Countries/Regions Semi-Solid Dose Sales Volume (%), (2020-2031)
Figure 41. United States Semi-Solid Dose Sales Value, (2020-2031) & (US$ Million)
Figure 42. United States Semi-Solid Dose Sales Value by Type (%), 2024 VS 2031
Figure 43. United States Semi-Solid Dose Sales Value by Application (%), 2024 VS 2031
Figure 44. Europe Semi-Solid Dose Sales Value, (2020-2031) & (US$ Million)
Figure 45. Europe Semi-Solid Dose Sales Value by Type (%), 2024 VS 2031
Figure 46. Europe Semi-Solid Dose Sales Value by Application (%), 2024 VS 2031
Figure 47. China Semi-Solid Dose Sales Value, (2020-2031) & (US$ Million)
Figure 48. China Semi-Solid Dose Sales Value by Type (%), 2024 VS 2031
Figure 49. China Semi-Solid Dose Sales Value by Application (%), 2024 VS 2031
Figure 50. Japan Semi-Solid Dose Sales Value, (2020-2031) & (US$ Million)
Figure 51. Japan Semi-Solid Dose Sales Value by Type (%), 2024 VS 2031
Figure 52. Japan Semi-Solid Dose Sales Value by Application (%), 2024 VS 2031
Figure 53. South Korea Semi-Solid Dose Sales Value, (2020-2031) & (US$ Million)
Figure 54. South Korea Semi-Solid Dose Sales Value by Type (%), 2024 VS 2031
Figure 55. South Korea Semi-Solid Dose Sales Value by Application (%), 2024 VS 2031
Figure 56. Southeast Asia Semi-Solid Dose Sales Value, (2020-2031) & (US$ Million)
Figure 57. Southeast Asia Semi-Solid Dose Sales Value by Type (%), 2024 VS 2031
Figure 58. Southeast Asia Semi-Solid Dose Sales Value by Application (%), 2024 VS 2031
Figure 59. India Semi-Solid Dose Sales Value, (2020-2031) & (US$ Million)
Figure 60. India Semi-Solid Dose Sales Value by Type (%), 2024 VS 2031
Figure 61. India Semi-Solid Dose Sales Value by Application (%), 2024 VS 2031
Figure 62. Semi-Solid Dose Industrial Chain
Figure 63. Semi-Solid Dose Manufacturing Cost Structure
Figure 64. Channels of Distribution (Direct Sales, and Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Semi-Solid Dose market?
The top companies in the global Semi-Solid Dose market are Johnson & Johnson、Merck & Co、Bayer AG.
Related Reports
Semi-Solid Dose- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Semi-Solid Dose was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-01
Pages: 105
USD 3950.00
(Single User License)
Global Semi-Solid Dose Market Research Report 2026
The global Semi-Solid Dose market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-01
Pages: 130
USD 2900.00
(Single User License)
Global Semi-Solid Dose Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Semi-Solid Dose market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 142
USD 4900.00
(Single User License)
Global Semi-Solid Dose Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Semi-Solid Dose market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 76
USD 4250.00
(Single User License)
Global Semi-Solid Dose Market Research Report 2025
The global market for Semi-Solid Dose was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-14
Pages: 94
USD 2900.00
(Single User License)
Global Semi-Solid Dose Market Insights, Forecast to 2030
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published Date: 2024-04-10
Pages: 112
USD 4900.00
(Single User License)
Global Semi-Solid Dose Market Research Report 2024
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published Date: 2024-02-14
Pages: 98
USD 2900.00
(Single User License)
Semi-Solid Dose - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published Date: 2024-01-04
Pages: 130
USD 3950.00
(Single User License)
Semi-Solid Dose- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Semi-Solid Dose was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-02-01
Pages: 105
USD 3950.00 (Single User License)Global Semi-Solid Dose Market Research Report 2026
The global Semi-Solid Dose market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-01
Pages: 130
USD 2900.00 (Single User License)Global Semi-Solid Dose Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Semi-Solid Dose market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 142
USD 4900.00 (Single User License)Global Semi-Solid Dose Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Semi-Solid Dose market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 76
USD 4250.00 (Single User License)Global Semi-Solid Dose Market Research Report 2025
The global market for Semi-Solid Dose was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-14
Pages: 94
USD 2900.00 (Single User License)Global Semi-Solid Dose Market Insights, Forecast to 2030
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published: 2024-04-10
Pages: 112
USD 4900.00 (Single User License)Global Semi-Solid Dose Market Research Report 2024
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published: 2024-02-14
Pages: 98
USD 2900.00 (Single User License)Semi-Solid Dose - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A type of medication that is neither solid nor liquid; they are somewhere in between the two states.
Published: 2024-01-04
Pages: 130
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now